September 14, 2024 – Lipidmetabolite

Erina B. Khotskaya1, Longfei Huo1, Kotaro Nakanishi3, Seung-Oe Lim1, Yi Du

Chemexpress September 14, 2024 0 Comments

Erina B. Khotskaya1, Longfei Huo1, Kotaro Nakanishi3, Seung-Oe Lim1, Yi Du1,2, Yan Wang1, Wei-Chao Chang4,five, Chung-Hsuan Chen5, Jennifer L. Hsu1,four,6, Yun Wu7, Yung Carmen Lam1, Brian P. James8, Xiuping Liu8,…

Uncategorized

F sufferers with resectable pancreatic cancer and feasibility for antibody therapy

Chemexpress September 14, 2024 0 Comments

F patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci 2006, 97:1191?197. 28. Sekikawa A, Fukui H, Fujii S, Takeda J, Nanakin A, Hisatsune H,…

Erina B. Khotskaya1, Longfei Huo1, Kotaro Nakanishi3, Seung-Oe Lim1, Yi Du

F sufferers with resectable pancreatic cancer and feasibility for antibody therapy

You Missed

2-Ethoxybenzamide (CAS 938-73-8)

2-cyclopropyl-4-methyl-6-(methylthio)pyrimidine-5-carboxylic acid

2-Cyano-N-(5-methyl-2-p-tolyl-2H-pyrazol-3-yl)-acetamide

2-(chloromethyl)-8-methylquinazolin-4(3H)-one